Fairy sells AERI 21.9: ANTH Rekindles Hope For Sollpura, AERI Launches Rockets, Pay Attention To ADHD
ADHD closed Monday's trading 1.22% higher at $19.10. Aerie Pharmaceuticals Inc. ( AERI) has initiated phase III registration clinical trials of Rhopressa, a novel once-daily, triple-action eye drop being tested for its ability to lower intraocular pressure ... ...
44 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home